Cholesterol crystals enhance TLR2-and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis by Køllgaard, Tania Maria Simonsen et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Cholesterol crystals enhance TLR2-and TLR4-mediated pro-inflammatory cytokine
responses of monocytes to the proatherogenic oral bacterium Porphyromonas
gingivalis
Køllgaard, Tania Maria Simonsen; Enevold, Christian; Bendtzen, Klaus; Hansen, Peter R.;
Givskov, Michael; Holmstrup, Palle; Nielsen, Claus H.
Published in:
P L o S One
DOI:
10.1371/journal.pone.0172773
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Køllgaard, T. M. S., Enevold, C., Bendtzen, K., Hansen, P. R., Givskov, M., Holmstrup, P., & Nielsen, C. H.
(2017). Cholesterol crystals enhance TLR2-and TLR4-mediated pro-inflammatory cytokine responses of
monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis. P L o S One, 12(2), [0172773].
https://doi.org/10.1371/journal.pone.0172773
Download date: 03. Feb. 2020
RESEARCH ARTICLE
Cholesterol crystals enhance TLR2- and
TLR4-mediated pro-inflammatory
cytokine responses of monocytes to
the proatherogenic oral bacterium
Porphyromonas gingivalis
Tania Køllgaard1, Christian Enevold1, Klaus Bendtzen1, Peter R. Hansen2,
Michael Givskov3, Palle Holmstrup4, Claus H. Nielsen1,4*
1 Institute for Inflammation Research, Center for Rheumatology and Spine Disease, Rigshospitalet,
Copenhagen University Hospital, Copenhagen, Denmark, 2 Department of Cardiology, Copenhagen
University Hospital Gentofte, Copenhagen, Denmark, 3 Costerton Biofilm Center, Department of
International Health, Immunology and Microbiology University of Copenhagen, Copenhagen, Denmark,
4 Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of
Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
* claushnielsen@hotmail.com
Abstract
Cholesterol deposits and pro-inflammatory cytokines play an essential role in the pathogen-
esis of atherosclerosis, a predominant cause of cardiovascular disease (CVD). Epidemio-
logical evidence has linked periodontal disease (PD) with atherosclerotic CVD. Accordingly,
viable periodontal pathogens, including Porphyromonas gingivalis, have been found in ath-
erosclerotic plaques in humans and mice. We aimed to determine whether cholesterol crys-
tals (CHCs) and oral bacteria synergize in the stimulation of human monocytes. Incubation
of human monocytes with CHCs induced secretion of interleukin (IL)-1β, tumor necrosis fac-
tor (TNF)-α, IL-6, and IL-8. Moreover, CHCs markedly enhanced secretion of IL-1β by
monocytes stimulated with the toll-like receptor (TLR) 4 agonist Escherichia coli lipopolysac-
charide (LPS), and the TLR2 agonist Staphylococcus aureus lipoteichoic acid. Notably,
CHCs also enhanced IL-1β secretion induced by P. gingivalis LPS and IL-1β secretion
induced by whole P. gingivalis bacteria. This enhancement was abrogated by the NLRP3
inflammasome inhibitors Z-YVAD-FMK and glibenclamide. CHCs had no effect on cytokine
production induced by P. gingivalis gingipains. Taken together, our findings support that
CHCs, via stimulation of NLRP3 inflammasomes, act in synergy with the periodontal patho-
gen P. gingivalis to promote monocyte secretion of pro-atherogenic cytokines.
Introduction
Growing evidence suggests that periodontal disease (PD) is a risk factor for atherosclerotic
cardiovascular disease (CVD) [1,2]. Atherosclerosis is generally accepted to be a chronic
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inflammatory disease in which the pro-inflammatory cytokines interleukin (IL)-1β and tumor
necrosis factor (TNF)-α play an important role [3,4]. Accumulation of cholesterol crystals
(CHCs) is thought to play an important role in atherosclerotic plaque destabilization and con-
sequent atherosclerotic disease manifestations, e.g. acute myocardial infarction and stroke
[5,6].
The major source of IL-1β and TNF-α in atherosclerotic lesions is macrophages, derived
from blood monocytes infiltrating the subintima [7]. Secretion of biologically active IL-1β
from monocytes and macrophages requires two activation signals. Signal 1 is delivered
through toll-like receptors (TLRs) and leads to transcription of pro-IL-1β, pro-IL-18 [8] and
pro-IL-33 [9]. Signal 2 is delivered by danger molecules, e.g. reactive oxygen species, and fun-
gal, bacterial and viral pathogens, which bind to nucleotide-binding oligomerization domain-
like receptors (NLRs) and cause assembly of multiprotein oligomers known as inflamma-
somes. Inflammasomes, in turn, activate caspase-1, which cleaves the precursor forms of the
cytokines into active IL-1β and IL-18 [8,10]. CHCs have been shown to trigger inflammation
by activation of the NLR family pyrin domain-containing 3 (NLRP3) inflammasome, leading
to secretion of active IL-1β and TNF-α from monocytes and macrophages primed with TLR
ligands, e.g. lipopolysaccharide (LPS) from Escherichia coli, cell wall components of Gram-pos-
itive bacteria, and oxidized low-density lipoprotein [11–13].
Much research has focused on pro-inflammatory conditions that facilitate the development
of atherosclerotic disease. One such condition is PD, which affects up to 50% of the adult pop-
ulation over 50 years of age in industrialized countries [14,15]. Viable periodontal bacteria
including Porphyromonas gingivalis have been found in atherosclerotic plaques in humans and
in mice [16–18]. A considerable body of evidence has linked this bacterium to the pathogenesis
of both PD and atherosclerotic CVD, but the underlying mechanisms remain unclear [19–21].
Oral infection with P. gingivalis and other bacteria induces secretion of IL-1β and TNF-α, as
revealed in the crevicular fluid [22,23]. This promotes local tissue damage due to hyperinflam-
mation, which may also cause systemic low-grade inflammation, and thereby increase the risk
of atherosclerotic CVD [14]. Moreover, inflammation also causes ulceration in the periodontal
pockets, thereby facilitating access of periodontal bacteria to the bloodstream, where they may
spread suspended in plasma or attached to red blood cells (as is the case for P. gingivalis),
thereby evading elimination by phagocytes [15,24], and subsequently gain access to the arterial
wall and contribute to atherogenesis.
Recently, it has been shown that CHCs enhance the production of IL-1β by human
macrophages primed with P. gingivalis LPS (Pg-LPS) [25]. However, results obtained with
purified Pg-LPS may not apply to whole bacteria. Thus, gingipains, a family of cysteine pro-
teases, constitute another major virulence factor of P. gingivalis, and are key players in the
stimulation of bone matrix destruction and modulation of host responses in PD [26]. For
example, the arginine (Arg) or lysine (Lys) specific gingipains of P. gingivalis may cleave
CD14, a receptor for LPS [27], leading to LPS hyporesponsiveness [27]. While other studies
have suggested that TLR2 is more important [28,29], recently Pg-LPS was shown to activate
TLR4 which led to induction of pro-inflammatory cytokines in human gingival fibroblasts
[30]. Regardless of the relative binding contribution of these TLRs, cleavage of CD14 by
P. gingivalis gingipains may compromise signaling through both. Of note, gingipains per se
stimulate the human monocytic cell line THP-1 for production of IL-8, IL-6, and monocyte
chemotactic peptide (MCP)-1, in a process involving protease-activated receptors (PAR)-1,
-2 and -3 [31], and human macrophages produce TNF-α after stimulation with both Arg-
and Lys-gingipains [32].
In this study, we examined the ability of CHCs to stimulate unprimed and primed mono-
cytes for production of the pro-inflammatory cytokines IL-1β, TNF-α and IL-6, the anti-
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inflammatory IL-10, and the chemokine IL-8. We also investigated the potential synergy
between CHCs on the one hand, and Pg-LPS, Arg-gingipain and whole P. gingivalis bacteria
on the other, in stimulation of these responses. In addition, we examined the role of inflamma-
somes in mediating P. gingivalis- and CHC-induced pro-inflammatory cytokine production.
Materials and methods
Cells
Blood from anonymous, healthy blood donors attending the Blood Bank at Copenhagen Uni-
versity Hospital, Rigshospitalet, Denmark was used. Peripheral blood mononuclear cells
(PBMCs) were isolated using Lymphoprep (Axis-shield, Oslo, Norway) gradient centrifuga-
tion. PBMCs were resuspended in RPMI 1640 with HEPES (Biological Industries, Haemek,
Israel), L-glutamine and gentamicin (Fischer Scientific, Slangerup, Denmark), and monocytes
were isolated using EasySepTM human CD14+ positive selection kit (STEMCELL technologies,
Grenoble, France) according to the manufacturer’s instructions. Purity was shown to be>90%
when tested by flow cytometry.
Cholesterol crystal preparation
Cholesterol99% (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 95% ethanol (12.5 g/
L), heated to 60˚C, filtered, and left at room temperature to allow crystallization in 15 mL poly-
propylene tubes (NuncTM, Fishcer Scientific, Slangerup, Denmark). CHCs were collected by
filtering and grinding using a sterile mortar. CHCs were stored in plastic tubes at -20˚C until
use. Any LPS contamination of CHCs was found to be below the detection limit of the Limulus
amebocyte lysate assay QCL-1000 kit (Lonza, Walkersville, MD, USA).
Stimulation of monocytes with LPS from P. gingivalis and E. coli,
lipoteichoic acid, and Arg-gingipain
Freshly isolated CD14+ monocytes were cultured overnight in Nunclon Delta microwell plates
(Thermo Fischer Scientific, Roskilde, Denmark) using 3x105 cells/well with 200 μL RPMI 1640
with no serum. The cells were incubated with 10.0 μg/mL Ultrapure LPS from P. gingivalis
(Pg-LPS) (Invivogen, San Diego, CA, USA), 0.01 and 1.0 μg/mL LPS from E. coli (Ec-LPS:
O55:B5 endotoxin; Lonza, Walkersville, MN, USA), and 0.1 and 1.0 μg/mL the TLR2 agonist
lipoteichoic acid from Staphylococcus aureus (Sa-LTA) (Invivogen, San Diego, CA, USA), in
the presence or absence of 2 mg/mL CHCs. Furthermore, isolated monocytes were stimulated
with Arg-gingipain (210 nM) (Ho¨lzel Diagnostika Handels GmbH, Ko¨ln, Germany). Before
use, Arg-gingipain was activated in RPMI 1640 and 10 mM cysteine for 10 minutes at 37˚C/
5% CO2, and then diluted in media. After 20 hours at 37˚C/5% CO2, supernatants were har-
vested and analyzed for the presence of cytokines. No endotoxin was detected in the Arg-gingi-
pain preparation.
Cytokine measurements
IL-1β, IL-6, IL-10, and TNF-α were measured in supernatants from cell cultures using the BD
Cytometric Bead Array Human Inflammation Kit (BD Bioscience, San Jose, CA, USA) as
described previously [33]. Data acquisition was done with a FACSCalibur flow cytometer (BD
Bioscience), and data were analyzed using the FCAPArray Software (Softflow, Burnsville, MN,
USA). IL-8 in supernatants was measured using the Luminex100 detection system (Luminex
Corporation, Austin, TX, USA) according to the manufacturer’s instructions.
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Blockade of TLR-2, TLR-4, the inflammasome, and IL-1 signaling
For blockade of TLR2 and TLR4, isolated monocytes were preincubated with 1 μg/mL mono-
clonal anti-TLR2 IgA (α-TLR2-IgA) (Invivogen, San Diego, CA, USA) or 2.5 μg/mL of the
TLR4 antagonist LPS from Rhodobacter sphaeroides (Rs-LPS) (Invivogen, San Diego, CA,
USA) for 30 minutes at 37˚C/5% CO2 before stimulation with whole Pg bacteria. For blockade
of inflammasome activity, 25 μM of the pan-caspase inhibitor Z-VAD-FMK (sc-3067, Santa
Cruz Biotechnology, Santa Cruz), various concentrations of the caspase-1/NLRP3 inhibitor,
Z-YVAD-FMK (Abcam, Cambridge, UK) (1, 10, and 100 μM), and the ATP-sensitive potas-
sium channel inhibitor/NLRP3 inhibitor, glibenclamide (Invivogen, San Diego, CA, USA) (5,
25, and 50 μg/mL) were added. For blockade of IL-1 signaling, 2 ng/mL of the IL-1 receptor
antagonist (IL-1RA) (Novus Biologicals, Cambridge, UK) was added.
Stimulation of monocytes with whole bacteria
P. gingivalis (ATCC 33277) was cultured on trypticase soy blood agar plates containing 5 mg/
mL hemin and 50 μg/L Vitamin K for 4 days at 37˚C/10% CO2/10% H2O/80% N2. Subse-
quently, the bacteria were frozen in phosphate-buffered saline, pH 7.4, and kept at -80˚C. Iso-
lated CD14+ monocytes were stimulated overnight (3x105 cells/well) with 4x105 thawed whole
bacteria in RPMI 1640 with no serum added. After 20 hours at 37˚C/5% CO2, supernatants
were harvested and analyzed for the presence of cytokines.
Analyses of cell viability using flow cytometry
Purified CD14+ cells were stained with anti-CD14-antibody (BD Bioscience, San Jose, CA)
and 7-Amino Actinomycin D (7-AAD) and incubated on ice for 30 minutes. Cells were ana-
lyzed using a FACS canto II flow cytometer (BD Bioscience, San Jose, CA) and data were ana-
lyzed using FlowJo v.X, (TreeStar, Inc. Ashland, OR).
Statistical analyses
Statistical analyses were performed using GraphPad Prism 6.0 (GraphPad Software, CA,
USA). Data are presented as means±SDs. Cytokine secretion upon stimulation with and with-
out CHCs was compared using repeated measures ANOVA. Differences between paired data
were assessed using paired sample t-tests. The Bonferroni correction was used where indepen-
dent comparisons were made. Data were log10-transformed to obtain normal distribution
when indicated. P<0.05 was considered significant.
Results
Monocyte cytokine responses to CHCs
While examining the ability of CHCs to stimulate production of pro-inflammatory cytokines
by unprimed human monocytes, we observed significant secretion of IL-1β, TNF-α, IL-6 (Fig
1A–1C), and a statistical trend towards IL-8 secretion (Fig 1E). The CHC concentration used
(2 mg/mL) was based on preliminary titration studies (S1 Fig).
Influence of CHCs on TLR4-mediated cytokine responses
We next examined the influence of CHCs on monocyte cytokine responses induced by LPS
from E. coli (Ec-LPS), a classic TLR4 agonist (Fig 1). The CHCs enhanced IL-1β responses to
Ec-LPS at two concentrations (0.01 and 1 μg/mL) (Fig 1F) without affecting the production of
TNF-α, IL-6, IL-10, and IL-8 (Fig 1G–1J).
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Influence of CHCs on TLR2-mediated cytokine responses
Further we examined the effect of CHCs on TLR2-induced cytokine responses by stimulating
monocytes with the TLR2 agonist Sa-LTA. Dose-dependent secretion of IL-1β, IL-6, IL-10,
and IL-8 was observed (Fig 2). Again, IL-1β secretion was enhanced by co-incubation with
CHCs at 0.1 and 1.0 μg/mL of Sa-LTA (Fig 2A), while CHCs had no effect on secretion of the
other cytokines (Fig 2B–2E).
Influence of CHCs on cytokine responses to P. gingivalis LPS
Examination of the monocyte cytokine responses to LPS from P. gingivalis confirmed previous
findings that TLR2 contributed to cytokine production induced by Pg-LPS [28,29] using a
TLR2-blocking antibody (anti-TLR2, clone B4H2), which inhibited the production of IL-1β by
29±42%, TNF-α by 55±27%, IL-6 by 60±46%, and IL-10 by 54±45% (S2A–S2D Fig). Secretion
of IL-8 was not affected by anti-TLR2 (S2E Fig).
Fig 1. Influence of cholesterol crystals (CHCs) on E. coli (Ec)-lipopolysaccharide (LPS)-induced
cytokine responses. (A–E) Isolated monocytes were stimulated with CHCs (2mg/mL) for 20 hours.
Interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6, IL-10, and IL-8 in supernatants were measured after
20 hours of incubation, and are shown as mean±SD for experiments using 9 healthy donors. (F–J) Isolated
monocytes were stimulated with Ec-LPS at two concentrations; 0.01 (low) and 1.0 (high) μg/mL in the
absence (black circles) or presence (white circles) of CHCs (2mg/mL). Concentrations of IL-1β, TNF-α, IL-6,
IL-10, and IL-8 in supernatants after 20 hours of incubation are shown as mean±SD for experiments using 4
healthy donors.
doi:10.1371/journal.pone.0172773.g001
Fig 2. Influence of cholesterol crystals (CHCs) on toll-like receptor (TLR) 2-induced cytokine
responses. (A–E) Isolated monocytes were stimulated with the TLR2 agonist lipoteichoic acid from
Staphylococcus aureus (Sa-LTA) at two concentrations; 0.1 (low) and 1.0 μg/mL (high) in the absence (black
circles) or presence (white circles) of CHCs (2 mg/mL). Concentrations of interleukin (IL)-1β, tumor necrosis
factor (TNF)-α, IL-6, IL-10, and IL-8 in supernatants after 20 hours of incubation are shown as mean±SD for
experiments using 5 healthy donors.
doi:10.1371/journal.pone.0172773.g002
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Pg-LPS-induced secretion of IL-1β was greatly enhanced in a dose-dependent manner (Fig
3A) by co-stimulation with CHCs. In contrast, CHCs mediated a dose-dependent lowering of
Pg-LPS-induced secretion of TNF-α, IL-6 and IL-10 (Fig 3B, 3C and 3D). Addition of CHCs
did not affect the Pg-LPS induced secretion of IL-8 (Fig 3E).
Influence of CHCs on cytokine responses to P. gingivalis gingipains
The cytokine production induced by another constituent of P. gingivalis, the cysteine protease
Arg-gingipain activated by cysteine in vitro and added to monocyte cultures showed that Arg-
gingipain induced secretion of IL-1β and TNF-α (Fig 3F and 3G), but not of IL-6, IL-10 (Fig
3H and 3I), and IL-8 (data not shown). Furthermore, CHCs did not influence IL-1β or TNF-α
secretion (Fig 3F and 3G).
Role of inflammasomes in cytokine responses to Pg-LPS and CHCs
To investigate the role of the inflammasome in the synergistic effect of Pg-LPS and CHCs on
monocyte responses, the pan-caspase inhibitor Z-VAD-FMK was included in the experiments
at a concentration of 25 μM, which was chosen on the basis of titration studies (S3A Fig).
Z-VAD-FMK abolished secretion of IL-1β by monocytes stimulated with CHCs alone, con-
firming that CHCs induced IL-1β production by monocytes in an inflammasome-dependent
manner (S3B Fig). Importantly, incubation of monocytes for 20 hours with Z-VAD-FMK at
concentrations ranging from 5–25 μM did not cause significant cell death (S3C Fig). The
enhancing effect of CHCs on Pg-LPS-induced IL-1β secretion by monocytes was abrogated by
addition of Z-VAD-FMK (S3D Fig). In addition, production of TNF-α, IL-6, IL-10, and IL-8
after stimulation with Pg-LPS and CHCs was inhibited by Z-VAD-FMK (S3E–S3H Fig).
To further investigate the role of the NLRP3 inflammasome, we included the caspase-1/
NLRP3 inhibitor, Z-YVAD-FMK, and the ATP-sensitive potassium channel/NLRP3 inhibitor,
Fig 3. Influence of cholesterol crystals (CHCs) on cytokine responses induced by P. gingivalis
lipopolysaccharide (Pg-LPS). (A–E) Isolated monocytes were stimulated with CHCs in different
concentrations in the absence (black circles) or presence (white circles) of Pg-LPS (10 μg/mL). Concentrations
of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6, IL-10 and IL-8 in supernatants after 20 hours are
shown as means±SD for experiments using 3 healthy donors. (F-I) Isolated monocytes were cultured with no
stimulation, Arg-gingipain, CHCs, and Arg-gingipain and CHCs combined. The content of IL-1β, TNF-α, Il-6,
and IL-10 in supernatants after 20 hours is shown as means±SD for experiments using 6 healthy donors.
doi:10.1371/journal.pone.0172773.g003
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glibenclamide in the experiments. Both Z-YVAD-FMK and glibenclamide caused a dose-
dependent decrease in IL-1β secretion by monocytes stimulated with a combination of Pg-LPS
and CHCs, confirming that NLRP3 was critically involved in the induction of IL-1β secretion
(Fig 4A and 4F). In addition, secretion of TNF-α was lowered by both Z-YVAD-FMK and
glibenclamide (Fig 4B and 4G), while the two NLRP3 inhibitors had no effect on the produc-
tion of IL-6, or IL-8 (Fig 4C, 4D, 4E, 4H, 4I and 4J). The data on IL-10 were ambiguous (Fig
4D and 4I).
Addition of each inhibitor separately did not completely abolish secretion of IL-1β. How-
ever, addition of the inhibitors in combination at the highest concentration resulted in com-
plete inhibition of IL-1β production (data not shown).
To examine the role of IL-1β for induction of TNF-α, IL-1 receptor antagonist (IL-1RA)
was included in the experiments. IL-1RA did not affect secretion of IL-1β significantly (Fig
5A), but inhibited the production of TNF-α (Fig 5B), indicating a role for IL-1β in induction
of TNF-α, as also observed by others [34]. In addition, IL-6 production was nonsignificantly
lowered after addition of IL-1RA (Fig 5C). Secretion of IL-10 and IL-8 was not affected by
addition of IL-1RA (Fig 5D and 5E).
The notion that secretion of TNF-α was a consequence of stimulation with IL-1β was sup-
ported by the finding that IL-1β secretion production preceded TNF-α secretion by approxi-
mately 3 hours (Fig 5F).
Influence of CHCs on cytokine responses to whole bacteria
Incubation of monocyte cultures with P. gingivalis as whole bacteria led to production of IL-
1β, TNF-α, IL-6, IL-10, and IL-8 (Fig 6A–6E). Addition of anti-TLR2 and Rs-LPS, separately
or in combination, lowered secretion of all cytokines (Fig 6A–6E), demonstrating the involve-
ment of both TLR2 and TLR4 in their induction. Anti-TLR2 and Rs-LPS inhibited the produc-
tion of IL-1β by 65±18% and 44±17%, respectively, with no additive effect of their combined
use (data not shown).
Fig 4. Role of the NLRP3 inflammasome in induction of cytokine responses to cholesterol crystals
(CHCs) and P. gingivalis lipopolysaccharide (Pg-LPS). (A–E) Freshly isolated monocytes were cultured
in presence of Pg-LPS (10 μg/mL) and CHCs, and the caspase-1 inhibitor Z-YVAD-FMK was added in
concentrations of 5, 25 and 50 μg/mL. Concentrations of interleukin (IL)-1β, tumor necrosis factor (TNF)-α,
IL-6, IL-10, and IL-8 in supernatants after 20 hours of incubation were measured, and data were normalized to
P. gingivalis+CHCs. Data are shown as means±SD for experiments using 3 healthy donors. (F–J) Freshly
isolated monocytes were cultured in presence of P. gingivalis lipopolysaccharide (Pg-LPS) (10 μg/mL)
and CHCs (2 mg/mL), and the ATP-sensitive potassium channel inhibitor glibenclamide was added at
concentrations of 1, 10 and 100 μM. Concentrations of IL-1β, TNF-α, IL-6, IL-10, and IL-8 in supernatants
after 20 hours of incubation were measured, and data were normalized to P. gingivalis+CHCs. Data are
shown as means±SD for experiments using 5 healthy donors.
doi:10.1371/journal.pone.0172773.g004
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The pan-caspase inhibitor Z-VAD-FMK completely abolished secretion of IL-1β, TNF-α,
IL-6, IL-10, and IL-8 (Fig 6A–6E), demonstrating a critical role for inflammasomes in induc-
tion of all these cytokines by whole bacteria.
As observed for Pg-LPS (Fig 3A), CHCs markedly enhanced the secretion of IL-1β induced
by whole bacteria (Fig 6A). In contrast, CHCs lowered the secretion of TNF-α, IL-6, IL-10,
and IL-8 (Fig 6B–6E). Secretion of IL-1β, TNF-α, IL-6, IL-10, and IL-8 induced by P. gingivalis
and CHCs was abrogated by Z-VAD-FMK, demonstrating the critical role of inflammasomes,
also under these conditions (Fig 6A–6E).
Discussion
Accumulation of CHCs plays a crucial role in atherogenesis, possibly via induction of pro-
inflammatory cytokine responses through inflammasomes [5,6,11,12,25]. Infection with P. gin-
givalis which is thought to be a keystone pathogen in PD [20], has also been linked to the path-
ogenesis of atherosclerotic CVD [14,15,19–21]. We therefore assessed the ability of CHCs to
stimulate human monocytes for secretion of pro-inflammatory cytokines and to enhance pro-
inflammatory cytokine responses to P. gingivalis, and we examined the role of inflammasomes
and TLRs in these processes.
Fig 5. Effect of interleukin (IL)-1β inhibition on P. gingivalis lipopolysaccharide (Pg-LPS)-induced
cytokine production. (A–E) Isolated monocytes were cultured without stimuli, or in the presence of Pg-LPS
(10 μg/mL) or Pg-LPS in combination with IL-1 receptor antagonist (IL-1RA). Concentrations of interleukin
(IL)-1β, tumor necrosis factor (TNF)-α, IL-6, IL-10, and IL-8 in supernatants after 20 hours are shown as
means±SD for experiments using 7 healthy donors. (F) Isolated monocytes were cultured with Pg-LPS
(10 μg/mL) and CHCs (2 mg/mL), and concentrations of IL-1β and TNF-α in supernatants were measured
after 1, 3 and 7 hours of incubation. Data are shown as average and range for experiments using 2 healthy
donors, normalized to the values obtained after 7 hours of incubation.
doi:10.1371/journal.pone.0172773.g005
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CHCs alone were capable of inducing monocyte secretion of IL-1β, an important inflam-
matory mediator in CVD and PD [3,35,36]. Similar observations were made by Rajama¨ki
et al., who used human adherent mononuclear cells and monocyte-derived macrophages [37].
Two other studies, however, found that CHCs alone did not induce IL-1β secretion by human
PBMCs [12] or monocyte-derived macrophages [25]. These discrepancies may be explained
by differences in incubation time (20 hours in our study versus 6 hours [12] and 6 days [25]),
and the fact that we did not include GM-CSF or M-CSF [25]. We further observed that CHCs
(2 mg/mL) alone induced secretion of TNF-α, IL-6, and IL-8 by monocytes. We recently
found that matrix-bound cholesterol failed to stimulate monocyte-derived spindle-shaped
cells for cytokine production [13], and this discrepancy may be due to differences in choles-
terol formulation and differentiation stage of the cell cultures.
We show here that CHCs markedly enhance secretion of IL-1β by monocytes stimulated
with the TLR4-ligand LPS from E. coli, supporting similar findings by Rajama¨ki et al. [37]. The
Ec-LPS-induced production of TNF-α was not affected, however. The reverse pattern was found
in our previous study using matrix-bound cholesterol [13]. CHCs also enhanced the secretion of
IL-1β by monocytes stimulated with the TLR2-ligand lipoteichoic acid from S. aureus.
A main focus of this study was to examine whether P. gingivalis and CHCs acted synergisti-
cally in stimulation of pro-inflammatory cytokine production by monocytes, a molecular
Fig 6. Toll-like receptor (TLR) 2-, TLR4- and caspase-dependent cytokine secretion of monocytes
stimulated with P. gingivalis and cholesterol crystals (CHCs). (A–E) Isolated monocytes incubated with
P. gingivalis (Pg), as whole bacteria, and CHCs in the presence of various combinations of an antibody
blocking TLR2 (anti-TLR2), the TLR4 antagonist lipopolysaccharide (LPS) from Rhodobacter sphaeroides
(Rs-LPS), and the pan-caspase inhibitor Z-VAD-FMK. Supernatant concentrations of interleukin (IL)-1β,
tumor necrosis factor (TNF)-α, IL-6, IL-10, and IL-8 after 20 hours of incubation are shown as means±SD for
experiments using 4 healthy donors. Background values obtained in the absence of stimuli were subtracted,
and data normalized to values obtained after incubation with P. gingivalis alone.
doi:10.1371/journal.pone.0172773.g006
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mechanism that could contribute to the association between PD and atherosclerosis. Indeed,
CHCs markedly enhanced secretion of IL-1β induced by LPS isolated from P. gingivalis, in
accordance with results of a recent study of human macrophages [25]. However, CHCs did
not enhance the Pg-LPS-induced production of TNF-α or IL-6. Another component of P. gin-
givalis, Arg-gingipain, which is considered a key virulence factor, induced secretion of IL-1β
and TNF-α, but not IL-6, IL-8 and IL-10. Similarly, previous studies showed that gingipains
induced IL-8 and TNF-α production by human macrophages [32] and IL-1β and IL-10 pro-
duction by the human monocytic cell line THP-1 [38]. Notably, CHCs did not enhance Arg-
gingipain-mediated secretion of IL-1β by monocytes.
To our knowledge, this is the first study to assess the combined effect of CHCs and whole
P. gingivalis bacteria on cytokine production by monocytes. P. gingivalis alone was a potent
inducer of IL-1β, TNF-α-, IL-6-, and IL-10 secretion, as also described previously [39,40], and
of IL-8 secretion, respectively, and TLR2 and TLR4 both contributed to P. gingivalis-mediated
induction of cytokine responses. Notably, CHCs enhanced P. gingivalis-induced secretion of
IL-1β by monocytes, but lowered the concomitant secretion of TNF-α, IL-6, IL-8, and IL-10.
The underlying mechanisms and the consequences of these responses with respect to athero-
sclerotic plaque development and stability remain to be studied.
The pan-caspase inhibitor Z-VAD-FMK abolished the ability of CHCs to induce IL-1β
secretion by monocytes and neutralized the CHC-mediated enhancement of IL-1β production
induced by Pg-LPS and whole P. gingivalis. This implied that CHCs exerted their effects on IL-
1β production via caspase activation, and thereby through inflammasomes. It has previously
been demonstrated that CHCs activate the NLRP3 inflammasome in Ec-LPS stimulated mac-
rophages [37] and human PBMC [12]. Here, we investigated the role of the NLRP3 inflamma-
some in the enhancement of IL-1β secretion induced by Pg-LPS and CHCs by use of the
NLRP3 inhibitors, Z-YVAD-FMK and glibenclamide. We demonstrated that the NLRP3
inflammasome is involved in the CHC-mediated enhancement of IL-1β production by mono-
cytes stimulated with LPS from the periodontal bacterium P. gingivalis.
In line with the findings of others [34], our experiments including IL-1RA showed that IL-
1β enhanced the secretion of TNF-α, IL-6 and IL-10, but not IL-8. Also, IL-1β secretion began
approximately 3 hours before TNF-α secretion.
Among the limitations of the study, it should be noted that we isolated monocytes based on
their expression of CD14, which is also expressed by macrophages. The cell cultures may there-
fore have contained macrophages at low frequencies.
In summary, we demonstrated an inflammasome-dependent role for CHCs in enhance-
ment of the pro-inflammatory cytokine responses of human monocytes exposed to the pro-
atherogenic periodontal bacterium P. gingivalis. This interaction may contribute to the associa-
tion between PD and atherosclerotic CVD.
Supporting information
S1 Fig. Dose-titration of cholesterol crystals (CHCs). Isolated monocytes were cultured with
no stimulation and CHCs at different concentrations (0.1, 0.5, 1, 2 and 4 mg/mL as indicated
by numbers after CHCs). The content of interleukin (IL)-1β in the supernatants after 20 hours
is shown as means±SD for experiments using two healthy donors.
(TIF)
S2 Fig. The role of toll-like receptors (TLR) 4 and TLR2 in cytokine responses upon stimu-
lation with E. coli (Ec)-lipopolysaccharide (LPS) and P. gingivalis (Pg)-LPS. (A-E) Isolated
monocytes were cultured with no stimulation, anti-TLR2, Pg-LPS) alone and Pg-LPS in com-
bination with anti-TLR2 antibody. The content of IL-1β (n = 11), TNF-α (n = 11), IL-6
Cholesterol crystals enhance monocyte responses to P. gingivalis
PLOS ONE | DOI:10.1371/journal.pone.0172773 February 24, 2017 10 / 14
(n = 11), IL-10 (n = 10) and IL-8 (n = 7) in the supernatants after 20 hours is shown as means
±SD. P-values were calculated from log10-transformed data using paired t-test.
(TIF)
S3 Fig. Dose titration of the pan-caspase inhibitor Z-VAD-FMK. (A) Isolated monocytes
were cultured with no stimulation, P. gingivalis (P.g)-lipopolysaccharide (LPS) and cholesterol
crystals (CHCs), and Pg-LPS and CHCs in combination with different concentrations of
Z-VAD-FMK (5, 10 and 25μM). Concentrations of interleukin (IL)-1β in the supernatants
after 20 hours are shown as means±SD for results of experiments using two healthy donors.
(B) Isolated monocytes were cultured with no stimulation, CHCs (2mg/mL) alone and in com-
bination with Z-VAD-FMK (25μM). Concentrations of IL-1β in the supernatants after 20
hours are shown as means±SD for experiments using 10 healthy donors. (C) Isolated mono-
cytes were cultured in presence of different concentrations of Z-VAD-FMK (5, 10, 25μM), Pg-
LPS (10 μg/mL), and Pg-LPS in combination with Z-VAD-FMK (25 μM). After 20 hours, cells
were stained with the dead cell marker 7-AAD and analyzed by flow cytometry. Frequencies of
living CD14+ cells are shown for experiments using two healthy donors. (D-H) Freshly iso-
lated monocytes were cultured in presence of Pg-LPS (10 μg/mL), Pg-LPS in combination
with CHCs, or Pg-LPS in combination with both CHCs and the pan-caspase inflammasome-
inhibitor Z-VAD-FMK. Concentrations of IL-1β, tumor necrosis factor (TNF)-α, IL-6, IL-10,
and IL-8 in supernatants after 20 hours are shown as mean±SD for experiments using seven
healthy donors.
(TIF)
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